Nu Skin Enterprises, Inc. (NYSE:NUS)

CAPS Rating: 2 out of 5

A global direct selling company with operations throughout Asia, the Americas and Europe. The Company develops and distributes personal care products and nutritional supplements sold under the Nu Skin and Pharmanex brands.

Results 1 - 20 of 41 : 1 2 3 Next »

Recs

0
Member Avatar kkconway (99.09) Submitted: 2/25/2015 1:12:28 PM : Outperform Start Price: $54.37 NUS Score: -26.91

Citicorp analyst, Greenblatt and Bernie Schaeffer, the options guru, all like this after a year of penance.

Recs

0
Member Avatar MrMighty (27.14) Submitted: 8/12/2014 3:29:47 PM : Outperform Start Price: $46.38 NUS Score: -24.85

Magic Formula.

Recs

0
Member Avatar MNDLBRT (35.17) Submitted: 6/9/2014 4:07:53 PM : Outperform Start Price: $71.01 NUS Score: -48.58

This company is the real deal with real science. There are questions from the FDA concerning verbiage and changing the verbiage will not change the science. You can buy cheap because some of their sales people in China likely overstepped their bounds and made claims that went too far. Who does not want to live healthy and long?

Recs

0
Member Avatar zhiyiwang (< 20) Submitted: 4/17/2014 3:48:21 AM : Outperform Start Price: $79.79 NUS Score: -58.47

China, big and long opportunity, for NUS.

Recs

0
Member Avatar healthcarevalue (97.87) Submitted: 3/17/2014 9:18:29 PM : Outperform Start Price: $70.82 NUS Score: -52.80

Price/earnings of 14.7. Debt/equity ratio of 0.16. Return on Invested Capital (ROIC) at just over 35 percent.

Recs

0
Member Avatar 2gud2btrue (< 20) Submitted: 2/27/2014 4:16:47 PM : Outperform Start Price: $79.64 NUS Score: -58.44

May be depends on tommorows earning call

Recs

0
Member Avatar Matthewin (36.26) Submitted: 2/26/2014 11:52:44 AM : Outperform Start Price: $78.84 NUS Score: -58.30

IT WILL SOAR BACK TO 100+

Recs

0
Member Avatar rishy709 (< 20) Submitted: 2/1/2014 7:23:29 PM : Outperform Start Price: $81.20 NUS Score: -63.63

what i have to say!!!!

Recs

0
Member Avatar alpineute (< 20) Submitted: 1/7/2014 5:10:05 PM : Outperform Start Price: $130.16 NUS Score: -75.77

Nuskin has been my best performing stock in the past 5 years. I have many close friends that work for the corporate office. One friend suggested I might buy the stock when it was priced at $10/share, which I did, though I can't complain about my over 1000% return, I should have bought more last year at $60 when he said again we just might hit $100. (As of today it's at $137) All signs point to higher growth internationally with good management, good products and an inspired sales force.

Recs

0
Member Avatar gpg777 (< 20) Submitted: 12/5/2013 5:42:37 AM : Outperform Start Price: $121.20 NUS Score: -76.18

Nuskin is a blessing :) The vehicle towards achieving my dreams..

Recs

0
Member Avatar NickChhabra (33.21) Submitted: 10/28/2013 1:34:45 PM : Outperform Start Price: $110.14 NUS Score: -75.25

Company has just scratched the surface in Asia. The opportunity is there for NUS to expand further for the next few years.

Recs

0
Member Avatar wildflower1975 (< 20) Submitted: 10/1/2013 8:10:01 PM : Outperform Start Price: $91.95 NUS Score: -74.32

Everyone wants to beat Aging

Recs

1
Member Avatar pramathmalik (82.12) Submitted: 7/12/2013 12:27:41 PM : Underperform Start Price: $72.72 NUS Score: +65.62

Cramer

Recs

0
Member Avatar WendyPluck (< 20) Submitted: 6/4/2013 2:32:52 PM : Outperform Start Price: $54.33 NUS Score: -52.95

Great new products in the pipeline

Recs

0
Member Avatar Teacherman333 (96.26) Submitted: 5/27/2013 12:23:42 PM : Outperform Start Price: $54.23 NUS Score: -52.88

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 36.84%
Trailing PE 16.41
PB 5.81
Div yield 2.00%

Recs

0
Member Avatar bajapa (< 20) Submitted: 11/16/2012 5:56:19 AM : Outperform Start Price: $40.83 NUS Score: -55.77

NUS has an outstanding track record of stable and continuous growth in the last 5 years. Sales, profit margins and several balance sheet ratios have improved every year. Only negative issue is their share buy back program. I personally favor receiving dividend instead. The accusations in the Citron Research Report seems highly exaggerated in order to benefit from short selling the stock. I have seen no other signs or evidence that the company has a problem with the Chinese government. The management has earned a huge credit by their past performance, and they have a good strategy in place to enhance sales in mainland China which are still making only 11% of the total sales of NUS at the moment. With an expected EPS of USD 3.45 for 2012 the stock is trading at 12.8 times earnings. Considering a conservatively estimated EPS growth of 15% per year for the coming 5 years (last 5 years EPS growth was 39% per year), and the stable growth pattern that is likely to continue I expect that the PE will eventually rise to 18 to reflect the real growth potential, making the stock climb to over USD 100 in 4 to 5 years from now.

Recs

0
Member Avatar DassanaJ (< 20) Submitted: 11/1/2012 11:36:16 AM : Outperform Start Price: $44.14 NUS Score: -55.27

Great product range. When economy slow down, more people get involved in direct selling. Especially in Asia.
Target - $55

Recs

0
Member Avatar markb002 (< 20) Submitted: 11/1/2012 1:14:34 AM : Outperform Start Price: $43.60 NUS Score: -55.36

Strong revenue growth and increased future outlook. Asian sales booming.

Recs

0
Member Avatar chopchop0 (72.64) Submitted: 10/29/2012 9:50:03 AM : Underperform Start Price: $39.64 NUS Score: +47.63

Sounds like an MLM scam

Recs

0
Member Avatar sweetpolly927 (< 20) Submitted: 4/19/2012 9:23:33 PM : Outperform Start Price: $53.31 NUS Score: -72.26

They have high end, cutting edge anti-aging products that will outperform any product in any spa in America. Their Galvanic Spa is the newest product that acts like a wrinkle iron.

Results 1 - 20 of 41 : 1 2 3 Next »

Featured Broker Partners